DARATUMUMAB
UNII 4Z63YK6E0E

Substance Identification & Data

This profile provides standardized clinical and technical data for Daratumumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4Z63YK6E0E.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 945721-28-8 and the RxNorm Concept ID (RxCUI) 1721947. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4Z63YK6E0E

CAS Registry Number

945721-28-8

RxNorm Concept ID

1721947

Detailed Substance Profile

Preferred Name

DARATUMUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

4Z63YK6E0E

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C74007

National Cancer Institute reference terminology for clinical and research data.

INN ID

9128

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

AB-73

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Daratumumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.